Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary non-small cell lung cancer response upon treatment with denosumab.

Lung cancer (Amsterdam, Netherlands) - 1 Dec 2013

Curioni-Fontecedro A, Husmann L, Soldini D, Stahel R A

Abstract excerpt

Here we report the case of a patient with metastatic adenocarcinoma of the lung harboring an ALK gene translocation. In this patient a response of the primary tumor and metastases has been detected upon treatment with denosumab. A possible link between ALK and RANK is postulated.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Antibodies, Monoclonal, Humanized
Share to Bronchoscopy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-1

Share to RANK Ligand

Share to Receptor Protein-Tyrosine Kinases

Share to Remission Induction

Source

Identifiers

PMID: 24075124
DOI: 10.1016/j.lungcan.2013.08.030

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24075124-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Primary non-small cell lung cancer response upon treatment with denosumab.PMID 24075124Read ↗

Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.Semantic proximity Read ↗

Signaling pathways modulating dependence of lung cancer on mutant epidermal growth factor receptor and mechanisms of intrinsic and acquired resistance to tyrosine kinase inhibitors.Semantic proximity Read ↗

The Change in Paradigm for NSCLC Patients with EML4–ALK TranslocationSemantic proximity Read ↗

Case Report of Non–Small Cell Lung Cancer with STRN-ALK Translocation: A Nonresponder to AlectinibSemantic proximity Read ↗

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical OverviewSemantic proximity Read ↗

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.Semantic proximity Read ↗

Circulating Tumor DNA Analysis in Blood for the Prediction of Treatment Response in Patientswith Advanced Non-Small Cell Lung CancerSemantic proximity Read ↗

The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.